Literature DB >> 9084070

Effects of venlafaxine in the sleep architecture of rats.

R J Salin-Pascual1, M L Moro-Lopez.   

Abstract

Different venlafaxine doses (1, 5, and 10 mg/kg) and saline solution were administered to ten male Wistar rats (Latin-Square design). Compared with saline, venlafaxine produced a dose-related suppression of REM sleep and an increase in wake time while slow wave sleep was reduced. This effect is similar to the one that has been reported with some tricyclic antidepressants.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9084070     DOI： 10.1007/s002130050194

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  5 in total

Review 1.  Drug effects on REM sleep and on endogenous depression.

Authors:  G W Vogel; A Buffenstein; K Minter; A Hennessey
Journal:  Neurosci Biobehav Rev       Date:  1990       Impact factor: 8.989

Review 2.  Cholinergic receptor subtypes and REM sleep in animals and normal controls.

Authors:  J C Gillin; R Salin-Pascual; J Velazquez-Moctezuma; P Shiromani; R Zoltoski
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

Review 3.  Venlafaxine. A review of its pharmacology and therapeutic potential in depression.

Authors:  S M Holliday; P Benfield
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

Review 4.  Pharmacologic profile and efficacy of venlafaxine.

Authors:  J Mendlewicz
Journal:  Int Clin Psychopharmacol       Date:  1995-03       Impact factor: 1.659

Review 5.  Safety and tolerance profile of venlafaxine.

Authors:  P Danjou; D Hackett
Journal:  Int Clin Psychopharmacol       Date:  1995-03       Impact factor: 1.659
  5 in total
  4 in total

1.  Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.

Authors:  Raymond Cespuglio; Colette Rousset; Gabriel Debilly; Catherine Rochat; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 2.  Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.

Authors:  Claire Rampon; Bruno P Guiard; Basile Coutens; Antoine Yrondi
Journal:  Psychopharmacology (Berl)       Date:  2022-08-10       Impact factor: 4.415

Review 3.  Tolerability and safety of fluvoxamine and other antidepressants.

Authors:  H G M Westenberg; C Sandner
Journal:  Int J Clin Pract       Date:  2006-04       Impact factor: 2.503

4.  In-Home Sleep Recordings in Military Veterans With Posttraumatic Stress Disorder Reveal Less REM and Deep Sleep <1 Hz.

Authors:  Julie A Onton; Scott C Matthews; Dae Y Kang; Todd P Coleman
Journal:  Front Hum Neurosci       Date:  2018-05-11       Impact factor: 3.169
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.